Clinical trial
Safety and Effect of Mirapex(Pramipexole) Tablet Among Korean RLS
NCT01170091 is registered in ClinicalTrials.gov with Boehringer Ingelheim as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Safety and Effect of Mirapex(Pramipexole) Tablet Among Korean RLS
- Lead sponsor
- Boehringer Ingelheim
- Phase
- Observational
- Overall status
- Completed
- Start date
- December 31, 2007
- Completion date
- Not reported
- Enrollment
- 651 (actual)
- Sites
- 36
Conditions
As the registry lists them; a condition with its own page is linked.